Clinical Trial Update: A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea [Phase 1]

View source ↗

Summary

Phase 1 trial comparing two Metronidazole 1% topical gel formulations for rosacea has completed. The study assessed equivalence between the formulations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• Metronidazole 1% topical gel - Formulation A (metronidazole)
• Metronidazole 1% topical gel - Formulation B (metronidazole)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Rosacea | Phase 1 | Status: COMPLETED